Tamoxifen Prediction Study in Patients With ER+ Breast Cancer

Clinical trial NCT05525481 · UNKNOWN

Trial details

NCT number: NCT05525481
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

ER+ Breast Cancer

Start date: 2022-11-01
Primary completion: 2023-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.